Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprep with/without Simethicone for Colonoscopy
NCT02523911Withdrawn
- Sponsor
- MercyOne Des Moines Medical Center
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in colorectal cancer (CRC) comparing Simethicone Group with Placebo Group (2 arms). Primary endpoint: Overall bowel cleansing. Planned start Mar 2016; status: withdrawn.
02
Drugs
simethicone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02523911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523911.